subject area of
- Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project Academic Article
- Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a “Black Box” Warning: A Canadian Tertiary Care Center Study Academic Article
- Fondaparinux for Treatment of Heparin-Induced Thrombocytopenia Academic Article
- NMDA-receptor Antagonism in Pediatric Pancreatitis Academic Article
- Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis Academic Article
- Off-label use of inhaled tobramycin in Ontario, Canada Academic Article
- Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report) Academic Article
- Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey Academic Article
- Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients Academic Article
- Unwarranted claims of drug efficacy in pharmaceutical sales visits: are drugs approved on the basis of surrogate outcomes promoted appropriately? Academic Article
- Voting with your fondaparinux Academic Article